نتائج البحث - Mohammed Milhem

تنقيح النتائج
  1. 1
    Work-related musculoskeletal disorders among physical therapists: A comprehensive narrative review

    Work-related musculoskeletal disorders among physical therapists: A comprehensive narrative review حسب Mohammed Milhem, Leonid Kalichman, David Ezra, Deborah Alperovitch‐Najenson

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Current status of intralesional agents in treatment of malignant melanoma

    Current status of intralesional agents in treatment of malignant melanoma حسب Misam Zawit, Umang Swami, Hassan Awada, Joyce Arnouk, Mohammed Milhem, Yousef Zakharia

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Pembrolizumab Therapy Triggering an Exacerbation of Preexisting Autoimmune Disease

    Pembrolizumab Therapy Triggering an Exacerbation of Preexisting Autoimmune Disease حسب Sneha Phadke, Ramez Ghabour, Brian L. Swick, Andrea Swenson, Mohammed Milhem, Yousef Zakharia

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Insights into the Proteome of Gastrointestinal Stromal Tumors-Derived Exosomes Reveals New Potential Diagnostic Biomarkers

    Insights into the Proteome of Gastrointestinal Stromal Tumors-Derived Exosomes Reveals New Potential Diagnostic Biomarkers حسب Safinur Atay, Daniel W. Wilkey, Mohammed Milhem, Michael L. Merchant, Andrew K. Godwin

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Improved survival for extremity soft tissue sarcoma treated in high‐volume facilities

    Improved survival for extremity soft tissue sarcoma treated in high‐volume facilities حسب Tyler Abarca, Yubo Gao, Varun Monga, Munir R. Tanas, Mohammed Milhem, Benjamin J. Miller

    منشور في 2018
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Modification of hematopoietic stem cell fate by 5aza 2′deoxycytidine and trichostatin A

    Modification of hematopoietic stem cell fate by 5aza 2′deoxycytidine and trichostatin A حسب Mohammed Milhem, Nadim Mahmud, Donald Lavelle, Hiroto Araki, Joseph DeSimone, Yogen Saunthararajah, Ronald Hoffman

    منشور في 2004
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents

    Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents حسب Hiroto Araki, Nadim Mahmud, Mohammed Milhem, Rafael Núñez, Mingjiang Xu, Craig A. Beam, Robert S. Hoffman

    منشور في 2006
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide)

    Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide) حسب Chang Xia, Roberto A. Leon‐Ferre, Douglas Laux, Jeremy Michael Deutsch, Bruce A. Smith, Melanie Frees, Mohammed Milhem

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I Trial

    Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I Trial حسب Espen B. Ellingsen, Steven O’Day, Artur Mezheyeuski, Agnieszka Gromadka, Trevor Clancy, Timothy S. Kristedja, Mohammed Milhem, Yousef Zakharia

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Epigenetic Silencing of the Human <i>NOS2</i> Gene: Rethinking the Role of Nitric Oxide in Human Macrophage Inflammatory Responses

    Epigenetic Silencing of the Human <i>NOS2</i> Gene: Rethinking the Role of Nitric Oxide in Human Macrophage Inflammatory Responses حسب Thomas Groß, Karol Kremens, Linda S. Powers, Brandi Brink, Tina Knutson, Frederick E. Domann, Robert A. Philibert, Mohammed Milhem, Martha M. Monick

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Results of a prospective phase 2 study of pazopanib in patients with surgically unresectable or metastatic chondrosarcoma

    Results of a prospective phase 2 study of pazopanib in patients with surgically unresectable or metastatic chondrosarcoma حسب Warren Chow, Paul Frankel, Chris Ruel, Dejka M. Araujo, Mohammed Milhem, Scott H. Okuno, Lee Hartner, Samir D. Undevia, Arthur P. Staddon

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma

    Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma حسب Igor Puzanov, Mohammed Milhem, David R. Minor, Omid Hamid, Li Ai, Lisa Chen, Michael Chastain, Kevin Gorski, Abraham Anderson, Jeffrey Chou, Howard L. Kaufman, Robert H.I. Andtbacka

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Redox active metals and H2O2 mediate the increased efficacy of pharmacological ascorbate in combination with gemcitabine or radiation in pre-clinical sarcoma models

    Redox active metals and H2O2 mediate the increased efficacy of pharmacological ascorbate in combination with gemcitabine or radiation in pre-clinical sarcoma models حسب Joshua D. Schoenfeld, Zita A. Sibenaller, Kranti A. Mapuskar, Megan D. Bradley, Brett A. Wagner, Garry R. Buettner, Varun Monga, Mohammed Milhem, Douglas R. Spitz, Bryan G. Allen

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte‐macrophage colony‐stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma

    Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte‐macrophage colony‐stimulating factor for the treatment of unres... حسب Robert H.I. Andtbacka, Sanjiv S. Agarwala, David W. Ollila, Sigrun Hallmeyer, Mohammed Milhem, Thomas Amatruda, John Nemunaitis, Kevin J. Harrington, Lisa Chen, Mark Shilkrut, Merrick I. Ross, Howard L. Kaufman

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Results of a prospective phase 2 study of pazopanib in patients with advanced intermediate‐grade or high‐grade liposarcoma

    Results of a prospective phase 2 study of pazopanib in patients with advanced intermediate‐grade or high‐grade liposarcoma حسب Brian L. Samuels, Sant P. Chawla, Neeta Somaiah, Arthur P. Staddon, Keith M. Skubitz, Mohammed Milhem, Peter K. Kaiser, David C. Portnoy, Dennis A. Priebat, Mark S. Walker, Edward J. Stepanski

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials

    Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials حسب Sandra P. D’Angelo, Michelle R. Mahoney, Brian Andrew Van Tine, James N. Atkins, Mohammed Milhem, Balkrishna Jahagirdar, Cristina R. Antonescu, Elise Horvath, William D. Tap, Gary K. Schwartz, Howard Streicher

    منشور في 2018
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Cancer Cells Resist Mechanical Destruction in Circulation via RhoA/Actomyosin-Dependent Mechano-Adaptation

    Cancer Cells Resist Mechanical Destruction in Circulation via RhoA/Actomyosin-Dependent Mechano-Adaptation حسب Devon L. Moose, Benjamin L. Krog, Taehyung Kim, Lei Zhao, Sophia Williams‐Perez, Gretchen Burke, Lillian Rhodes, Marion Vanneste, Patrick Breheny, Mohammed Milhem, Christopher S. Stipp, Amy C. Rowat, Michael D. Henry

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Functional Genomic Screening Independently Identifies CUL3 as a Mediator of Vemurafenib Resistance via Src-Rac1 Signaling Axis

    Functional Genomic Screening Independently Identifies CUL3 as a Mediator of Vemurafenib Resistance via Src-Rac1 Signaling Axis حسب Marion Vanneste, Charlotte R. Feddersen, Afshin Varzavand, Elliot Y. Zhu, Tyler M. Foley, Lei Zhao, Kathleen H. Holt, Mohammed Milhem, Robert C. Piper, Christopher S. Stipp, Adam J. Dupuy, Michael D. Henry

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    TAZ and YAP are frequently activated oncoproteins in sarcomas

    TAZ and YAP are frequently activated oncoproteins in sarcomas حسب Colleen Fullenkamp, Sarah L. Hall, Omar Jaber, Brittany L. Pakalniskis, Erica Savage, Johanna Savage, Georgina Ofori‐Amanfo, Allyn M. Lambertz, Stephanie D. Ivins, Christopher S. Stipp, Benjamin J. Miller, Mohammed Milhem, Munir R. Tanas

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial

    Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial حسب Robert H.I. Andtbacka, Merrick Ross, Igor Puzanov, Mohammed Milhem, Frances A. Collichio, Keith A. Delman, Thomas Amatruda, Jonathan S. Zager, Lee D. Cranmer, Eddy C. Hsueh, Lisa Chen, Mark Shilkrut, Howard L. Kaufman

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: